Phlogistix LLC

Phlogistix LLC, based in Lenexa, KS, was established in 2011 to advance and license innovative neurodiagnostic and therapeutic technologies aimed at addressing neuroinflammation and its related conditions. The company is actively engaged in research to develop unique diagnostics and therapeutics for brain injuries, including traumatic brain injury and sports-related concussions.

Through the exploration of critical pathways involving coagulation and inflammation in the brain, Phlogistix scientists are synthesizing new genes to facilitate the production of unique proteins that can cross the blood-brain barrier. Their goal is to create groundbreaking treatments that support healthier and longer lives for athletes, veterans, and anyone affected by brain injuries.

Generated from the website